Klaus Engel CEO of Evonik Industries AG said :
The year 2015 was both challenging and successful for Evonik. Although the global economic situation deterio- rated noticeably as the year progressed, all in all we were nevertheless able to defend and improve our market positions. The consistent focus of our business portfolio on customer-oriented specialty chemicals, the further selective expansion of ca- pacities, and our continued investment in research and development all paid o for our company and its shareholders.
Our total sales increased by 5 percent to € 13,507 million, and adjusted EBITDA rose even faster, by 31 percent to € 2,465 million. Our EBITDA margin thus increased signi cantly to 18.2 percent, which is an outstanding result both in general and within our own industry. Our return on capital employed (ROCE) of 16.6 percent was also very high.
Adjusted net income rose by 44 percent to € 1,128 million. In order to ensure our shareholders bene t from our positive business development, the Ex- ecutive Board and Supervisory Board will propose to the Annual Shareholders’ Meeting in May that the dividend be increased from € 1.00 per share to € 1.15 per share.
Source : Evonik Industries AG Annual Report 2015, March 3, 2016